HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
    • Archived Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Webinars / What Do Patients Consider Meaningful Change and How Can Researchers Define It?

What Do Patients Consider Meaningful Change and How Can Researchers Define It?

Event Date: Jul 09, 2020

As outlined in the 21st Century Cures Act, one of the key initiatives of the US Food and Drug Administration (FDA) is the advancement of patient-focused drug development (PFDD). To this end, the FDA has released a series of four methodological guidance documents to facilitate systematic approaches to collecting and using meaningful patient and caregiver input to inform medical product development and regulatory decision making. The fourth guidance includes a section on meaningful within-patient change (i.e., improvement and/or deterioration from the patient’s perspective) and how it can be assessed by clinical outcome assessments (COAs). In this webinar, we will discuss the relevance of PFDD, and specifically meaningful change, to stakeholders and the methods used to define it.

Discussion Points

In this webinar, we will discuss:

  • An overview of PFDD, including the history and current status as it relates to clinical outcome assessments
  • How clinical and/or biomarker endpoints may be used in clinical studies, but what considerations are there for the selection of patient-reported endpoints? How do you choose a measure?
  • What should be measured from the patient’s perspective in a clinical study, and how do you know what concepts are relevant to patients and other stakeholders?
  • Current guidance on methods to ascertain meaningful change

Key Learning Objectives

Attendees of this webinar will understand:

  • The relevance of PFDD and why sponsors are being asked to include clinical outcome assessments in their product development clinical trials
  • What constitutes a meaningful change from the patient’s perspective
  • The current FDA-advised approach for ascertaining meaningful within-patient change

Click here for additional information and registration details.



You might also be interested in:

  • Trump's "Buy American" Executive Order Could Raise Drug Prices 08/06/2020
  • Tufts Analyzes Cost-Effectiveness Analysis for 1974-2018 07/28/2020
  • Government, Big Pharma, and The People: A Century of Dis-Ease 12/03/2020
  • Scientist.com Reveals Expanded HEOR, Value, and RWE Category,… 03/23/2021
  • Addressing the Affordability Crisis of Cell & Gene Therapies 12/16/2020
  • Patient Drug Costs Increased as Health Plans Promote… 08/07/2020
  • Scientist.com to Acquire HealthEconomics.Com, the World’s… 12/15/2020

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters

Syndicated Reports

Artificial Intelligence in Healthcare Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Component, Application, End User, and Geography

Healthcare Trends & Forecasts in 2021: Performance Expectations for the Healthcare Industry

Medical Affairs Outsourcing Market 2021 Overview, Trends, Size, Growth and 2028 Future Insights

Bioinformatics Market Research Report by Product, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19

White Papers

What to Look for in an Informatics Platform for Life Sciences R&D

Beyond The Field: Evolving Field Medical Engagement And Talent For The Future

Innovating the Delivery of Patient Support: Branded Patient Support programs for Today’s Health Consumer

Healthcare Cost Containment: Best Practices & Recommendations

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence and Access Marketplace
    • Visite the Marketplace
    • On-demand Webinar
  • Industry Events
    • HealthEconomics.Com Webinars
    • View Conferences
    • View Webinars
    • Archived Webinars
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute